BChE-IN-14
BChE-IN-14 (compound 19c) is a selective butyrylcholinesterase (BChE) inhibitor with IC50s of 0.23 and 0.011 μM for eqBChE and hBChE, respectively. BChE-IN-14 shows good blood brain barrier permeation and primary cell safety. BChE-IN-14 is able to restore cognitive impairment in vivo, it can be used for the research of Alzheimer’s disease.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2700896-78-0
- Formule: C24H29N
- Masse moléculaire:331.49
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
IC50: 0.23 μM (eqBChE), 0.011 μM (hBChE)[1]
BChE-IN-14 (0.0001-100 μM) inhibits eqBChE from house serum and hBChE with IC50s of 0.23 and 0.011 μM, respectively[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:ICR mice with oligomerized Aβ1-42 peptide injection[1]
-
Dosage:15 mg/kg
-
Administration:Oral gavage; 15 mg/kg for Aβ1-42 injection days 3-8
-
Result:Improved memory and cognitive function in vivo and showed a shorter latency than donepezil.
Chemical Information
-
CAS No. 2700896-78-0
-
Masse moléculaire 331.49
-
Formule C24H29N
-
SMILES
CCCCN(CC1=CC=C2C=CC=CC2=C1)CCCC3=CC=CC=C3
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)